LH
|
Laboratory Corporation of America Holdings
|
US
|
NYSE
|
LIPO
|
Lipella Pharmaceuticals Inc.
|
US
|
NASDAQ
|
LMDX
|
LumiraDx Limited
|
US
|
NASDAQ
|
LNTH
|
Lantheus Holdings, Inc.
|
US
|
NASDAQ
|
LOGC
|
LogicBio Therapeutics, Inc.
|
US
|
NASDAQ
|
LSTA
|
Lisata Therapeutics, Inc.
|
US
|
NASDAQ
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
MOTS
|
Motus GI Holdings, Inc.
|
US
|
NASDAQ
|
MTCR
|
Metacrine, Inc.
|
US
|
NASDAQ
|
MTP
|
Midatech Pharma PLC
|
US
|
NASDAQ
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
NAMS
|
NewAmsterdam Pharma Company N.V.
|
US
|
NASDAQ
|
NARI
|
Inari Medical, Inc.
|
US
|
NASDAQ
|
NDRA
|
ENDRA Life Sciences Inc.
|
US
|
NASDAQ
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
NRSN
|
NeuroSense Therapeutics Ltd.
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
US
|
NASDAQ
|
OMGA
|
Omega Therapeutics, Inc.
|
US
|
NASDAQ
|
OPTN
|
OptiNose, Inc.
|
US
|
NASDAQ
|
PAHC
|
Phibro Animal Health Corporation
|
US
|
NASDAQ
|